Calcium Gluconate Market Report 2026

Calcium Gluconate Market Overview

• Calcium Gluconate market size has reached to $118.01 billion in 2025 • Expected to grow to $165.39 billion in 2030 at a compound annual growth rate (CAGR) of 6.8% • Growth Driver: Osteoporosis Incidence Boosts Calcium Gluconate Market Growth • Market Trend: Advancements In Calcium Gluconate Market With Drug Development And Regulatory Approval • Europe was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Calcium Gluconate Market?

Calcium gluconate is a mineral supplement used to treat or prevent calcium deficiencies and to manage conditions such as hypocalcemia, osteoporosis, and certain muscle spasms. It works by replenishing calcium stores in the body, aiding in bone strength and muscle function. This is often administered intravenously or orally to restore normal calcium levels in the blood. The main forms of calcium gluconate are liquid, tablet, powder, and gel. Liquid refers to substances that flow freely and take the shape of their container, characterized by their ability to pour and adapt to the container's contours. The grade includes pharmaceutical grade, and food grade, which are used for applications such as food and beverage manufacturers, pharmaceutical, nutraceutical, cosmetic and personal care, and others. The end use includes emulsifier, bulking agents, and thickening agent.

What Is The Calcium Gluconate Market Growth Forecast?

The calcium gluconate market size is expected to see strong growth in the next few years. It will grow to $165.39 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to rising demand for nutraceuticals and dietary supplements, innovations in injectable calcium formulations, expansion of geriatric care and pediatric healthcare, adoption of preventive healthcare strategies, growth of emerging markets in asia-pacific. Major trends in the forecast period include rising incidence of hypocalcemia, growth in osteoporosis awareness programs, increasing adoption of intravenous supplements, expansion of nutraceutical and functional foods, development of pediatric and geriatric calcium formulations.

Global Calcium Gluconate Market Segmentation

1) By Form: Liquid, Tablet, Powder, Gel 2) By Grade: Pharmaceutical Grade, Food Grade 3) By Application: Food And Beverage Manufacturers, Pharmaceutical, Nutraceutical, Cosmetic And Personal Care, Other Applications 4) By End Use: Emulsifier, Bulking Agent, Thickening Agent Subsegments: 1) By Liquid: Injectable Solution, Oral Liquid, IV Infusion 2) By Tablet: Standard Tablets, Effervescent Tablets 3) By Powder: Oral Powder, Injectable Powder 4) By Gel: Topical Gel, Transdermal Gel

What Are The Drivers Of The Calcium Gluconate Market?

The increasing incidence of osteoporosis is expected to propel the growth of the calcium gluconate market going forward. Osteoporosis is a medical condition characterized by reduced bone density and strength, increasing the risk of fractures. The incidence of osteoporosis is rising due to sedentary lifestyles, inadequate calcium intake, hormonal imbalances, and age-related physiological changes. The calcium gluconate market supports osteoporosis management by providing a supplemental source of calcium to improve bone strength and reduce fracture risk. For instance, in March 2025 according to the British Pharmacological Society a UK-based Association In 2023, the majority of patients receiving osteoporosis treatments were females, 90.9% for denosumab, 80.8% for bisphosphonates, 98.9% for SERMs, 99% for tibolone, and 86.8% for teriparatide. Therefore, the increasing incidence of osteoporosis is driving the growth of the calcium gluconate industry. The increasing expenditure on healthcare is expected to propel the growth of the calcium gluconate market going forward. Healthcare refers to the organized system of medical services, professionals, facilities, and resources aimed at maintaining and improving the physical and mental well-being of individuals. Healthcare expenditure is rising due to aging populations, growing chronic disease burdens, advancements in medical technology, and increasing demand for high-quality healthcare services. The calcium gluconate market supports healthcare needs by providing a critical treatment option for conditions caused by low calcium levels, including hypocalcemia, cardiac complications, and certain toxicities. For instance, in 2024, according to economic forecasts from the Office for Budget Responsibility (OBR) and the UK Treasury, a UK-based non-departmental public body, the UK's planned health spending is projected to reach £192 billion ($244.43 billion) in the 2024/25 period, rising from £182 billion ($231.70 billion) in 2022/23. Therefore, increasing expenditure on healthcare is driving the growth of the calcium gluconate industry.

Key Players In The Global Calcium Gluconate Market

Major companies operating in the calcium gluconate market are Merck & Co. Inc., Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Eli Lilly and Company, Solvay, Viatris Inc., Baxter International Inc., Fresenius Kabi USA, Hikma Pharmaceuticals Inc., Amneal Pharmaceuticals Private Limited, Amphastar Pharmaceuticals, Jost Chemical Co., American Regent Inc., Coyne Chemical, Anhui Xingzhou Medicine Food Co. Ltd., Westco Chemicals Inc., Noah chemicals, ND Biotech Pvt Ltd, Global Calcium Private Limited, Foodchem, Pharma Cure Laboratories, Nivagen Pharmaceuticals Inc., Tianyi Food Additives Co. Ltd

Global Calcium Gluconate Market Trends and Insights

Major companies operating in the calcium gluconate market are focusing on developing and securing approvals for new calcium gluconate drug formulations to improve treatment availability, ensure high-quality therapeutic options, and address calcium deficiencies and related acute conditions more effectively. Drug development and approval refer to a multi-stage process that includes discovery, preclinical evaluation, clinical testing, and regulatory review, ultimately ensuring that a medication is safe, effective, and compliant with health authority standards before it reaches patients. For instance, in September 2023, Amneal Pharmaceuticals Inc., a US-based generics and specialty pharmaceutical company, received U.S. FDA abbreviated new drug application (ANDA) approval for calcium gluconate in sodium chloride injection, granted Competitive Generic Therapy designation with a 180-day exclusivity period, available in 1000 mg/50 mL and 2000 mg/100 mL small-volume parenteral bags used for treating acute symptomatic hypocalcemia in both pediatric and adult patients.

Regional Insights

Europe was the largest region in the calcium gluconate market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Calcium Gluconate Market?

The calcium gluconate market consists of sales of oral supplementation, calcium D-gluconate monohydrate, calcium D-gluconate gel and other injectable solutions. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Calcium Gluconate Market Report 2026?

The calcium gluconate market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the calcium gluconate industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.